Health Industries Research Companies (HIRC) has released its fall 2004 High Cost Injectable Service, a comprehensive examination of the industry trends creating shifts in high cost injectable drug benefits. This research features trends for eleven key medication classes and reviews utilization management tactics, benefit location, fixed and percentage copays, specialty pharmacy coverage, formulary management and physician reimbursement.
